Researchers are looking into improving sleep in order to alleviate chronic pain.
Patients suffering from postherpetic nearalgia found relief taking gabapentin.
Although there is currently no gold standard therapy for the treatment of fibromyalgia, a number of medications have shown modest efficacy in managing fibromyalgia-related pain, including pregabalin.
The effects of dronabinol, nabilone, and nabiximols on neuropathic pain were assessed.
Previous research has suggested a link between early use of pregabalin in pregnancy and congenital malformations.
While adherence was improved, health care costs were increased.
A 10-minute application resulted in significant reductions in pain scores.
Patients with trigeminal neuralgia face a significant burden of illness.
The patch used in the study is approved in the United States for postherpetic neuralgia and in Europe for PNP arising from any etiology.
Even minor improvements in fibromyalgia symptoms, depression, anxiety, and pain can have a significant impact on the quality of life in patients with fibromyalgia.
Transcranial random noise stimulation improved both physical and cognitive symptoms of fibromyalgia.
As the population ages, and as both the incidence of diabetes and the survival rates after chemotherapy treatment increase, the number of patients with neuropathic pain is expected to rise.
No significant between-group differences were observed for change in leg pain intensity and disability.
In patients with impaired sensory discrimination, pain descriptors, localization, and pain triggers are often vague or poorly defined.
Clinically and statistically significant reductions in peripheral neuropathy were seen following neurofeedback.
New evidence on diabetic neuropathy has emerged since the ADA's last published a position statement in 2005.
Patients who received concomitant NeP medications showed little difference in therapeutic response in comparison to those who received pregabalin alone.
Significant improvement were observed for sensitivity, depression, and anxiety, among others.
Patients with fibromyalgia had a high prevalence of TRAb positivity compared with control populations in previous studies.
Recent findings offer a new avenue for the development of peripheral analgesics with minimal adverse effects.
Patients with cancer or an autoimmune disease who underwent surgery were at a greater risk.
The guidelines were developed by a group of RLS experts from the US and Europe who utilized the American Academy of Neurology's 2004 guideline development manual.
Diabetes, waist circumference, and prediabetes were the main metabolic factors associated with neuropathy.
Even after loss of exclusivity, pregabalin has lower health care costs than gabapentin.
The group developed the algorithm through a year-long process of reviewing relevant published data.
The small study documented several cases of denervation and increased thermal thresholds in patients treated with LCIG.
The designation has been granted to potentially treat neuropathic pain associated with diabetic peripheral neuropathy.
The researchers found that the extent of pain relief and relief of pain-related sleep interference did not differ between the +GBN and −GBN cohorts for any dose of pregabalin.
No significant differences in treatment response were seen between the different categories of pain duration.
Higher self-regulatory fatigue linked to lower QOL scores relating to physical functioning, role limitations-physical, bodily pain, and general health.
Neurology Advisor Articles
- Growing Old Without Alzheimer's Pathology: What's the Secret?
- Minocycline May Slow Progression From Clinically Isolated Syndrome to Multiple Sclerosis
- Brain Inflammation Observed in Obsessive-Compulsive Disorder
- Extended-Release Amantadine Reduces Levodopa-Induced Dyskinesia in Parkinson's Disease
- Treating Post-Traumatic Headache After Concussion